I write on biomedical research, climate resilience and other topics of interest. Among my day jobs, I was associate director for communications and public affairs at Whitehead Institute for Biomedical Research, founding editor in chief of MIT’s technologyreview.com and executive editor at pcworld.com. benderwrite @ gmail.com, @ebender00, 86 Greenlawn Avenue, Newton, MA 02459 USA
Finding medical value in mescaline
After millennia of sacramental use, mescaline is finally entering fully powered clinical trials.
Urban evolution: How species adapt to survive in cities
Plants and animals are evolving in cities around the world — offering ways to study longstanding scientific questions and clues to where climate change is taking us.
Knowable, 2022 (also picked up by Scientific American)
Facing the challenge of eliminating hepatitis B
Public-health expert Corinna Dan charts a course to free the United States from the virus.
Stem cells scaled up
Therapies based on induced pluripotent stem cells are hard enough to grow at a small scale. How will they be mass-produced for the clinic?
What survives the storm
StEER engineers flock into the site of natural disasters to support first responders and learn from the destruction.
Hakai, 2021 (also picked up by Smithsonian, The Atlantic)
The case for ocean optimism
With the health of the ocean under threat, a rallying cry for marine conservation goes global.
Knowable, 2021 (also picked up by Smithsonian)
Creating T cells to guard against autoimmune disease
Biotechnology companies are engineering regulatory T cells to help protect the body from friendly fire.
A $26-Billion Plan to Save the Houston Area from Rising Seas
Lawmakers are poised to decide the fate of a massive project to protect the coast around Houston from rising sea levels.
Undark, 2021 (also picked up by Popular Science, Salon, Wired, others)
Getting a Covid-19 vaccine — quickly and safely
Researchers around the globe are working with unprecedented speed to find the vaccines we need to find our way through the pandemic. What’s the bar for safety and effectiveness?
Could a bacteria-stuffed pill cure autoimmune diseases?
Researchers are investigating how the community of microbes living in the gut might help people with multiple sclerosis, lupus and type 1 diabetes.
Unpacking the black box in artificial intelligence for medicine
Deep learning will radically change aspects of our medical care. How well do we need to understand how AI tools work?
Breaking out of the egg
Can the latest techniques speed up the dangerously slow production of flu vaccines?
Now in development: off-the-shelf stem cells
Their potential as universal donors promises to make regenerative medicine more broadly practical.
Biotechs race to develop stem cell treatments for diabetes
Insulin-producing cells grown in the lab could offer a functional cure for the disease.
The Scientist, 2019
Regulating the gene-therapy revolution
The medical regulatory authorities ride a wave of clinical studies for gene therapies.
With storms intensifying and oceans on the rise, Boston weighs strategies for staying dry
A multi-billion-dollar seawall is among climate adaptation options under consideration for the iconic coastal city.